Cardiovascular Disease
Peter Libby, MD, to keynote annual CMHC, with focus on revolutionizing atherosclerosis care
The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.
Deep-learning model based on retinal images may help assess cardiovascular disease risk
The retinal image-based, deep-learning cardiac BioAge model accurately stratified individuals by traditional cardiovascular disease risk biomarkers, with leukocyte telomere length inversely related to BioAge score, researchers reported.
Premature menopause may negate ‘longevity benefit’ of women vs. men
Menopause onset before age 40 years appears to negate a longevity benefit women typically have over men, particularly among women who also undergo hormone therapy, researchers reported.
Q&A: Overlooked health issues that ‘need to be addressed’ in Asian communities
Asian American, Native Hawaiian and Pacific Islander, or AA and NH/PI, communities continue to face significant racial disparities in health care access and outcomes across the United States, according to an expert.
Levothyroxine therapy may reduce CV risk for adults with subclinical hypothyroidism
Adults with subclinical hypothyroidism may have a lower risk for major adverse cardiovascular events if they receive levothyroxine therapy compared with no treatment, according to a study published in Thyroid.
Consuming fruits, vegetables may benefit hypertension treatment, reduce CKD progression
Fruits and vegetables may be beneficial in the treatment of hypertension to reduce chronic kidney disease progression, according to published data.
Bariatric surgery does not reduce risk for cancer, heart disease among older adults
Bariatric surgery did not reduce risk for obesity-related cancer or cardiovascular disease compared with nonoperative treatment among adults aged at least 60 years, according to results of a population-based cohort study.
Diagnosis of Diabetes and the Metabolic Syndrome
CPAP lowers vascular inflammation, unstable plaque volume in OSA
Adults with obstructive sleep apnea treated with CPAP for 24 weeks had improved vascular inflammation and lower unstable plaque volume, according to results published in Annals of the American Thoracic Society.
MACE, malignancies rarer in Latin American patients with rheumatoid arthritis
Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.